ANTON GUETH Insider Trading $ATRS ANTARES PHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANTON GUETH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANTON GUETH. ANTON GUETH is Director in ANTARES PHARMA, INC. ($ATRS).
ANTON GUETH in ANTARES PHARMA, INC.
Trading Symbol: ATRSIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ANTON GUETH: Director
Holdings: 252,776 shares
Current Value: $556,107
Latest Transaction: Aug 13 2014
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANTON GUETH in ANTARES PHARMA, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 13 2014 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | P | 2.00 | 5,000 | 10,000 | 252,776 | 247.8 K to 252.8 K (+2.02 %) |
Jun 02 2014 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 3.09 | 61,930 | 191,364 | 268,881 | |
Sep 05 2013 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Sell | S | 4.42 | 25,000 | 110,570 | 245,976 | 271 K to 246 K (-9.23 %) |
Aug 05 2013 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Sell | S | 4.41 | 25,000 | 110,355 | 270,976 | 296 K to 271 K (-8.45 %) |
Jul 03 2013 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Sell | S | 4.15 | 25,000 | 103,685 | 295,976 | 321 K to 296 K (-7.79 %) |
Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Sell | S | 4.01 | 25,000 | 100,355 | 320,976 | 346 K to 321 K (-7.23 %) |
May 24 2013 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 0.00 | 27,778 | 0 | 345,976 | 318.2 K to 346 K (+8.73 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.60 | 40,000 | 64,000 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.10 | 26,009 | 28,610 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.53 | 174,849 | 92,670 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.85 | 105,616 | 89,774 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.65 | 61,870 | 102,086 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.55 | 10,000 | 15,500 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.54 | 20,000 | 30,800 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.40 | 20,000 | 28,000 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.40 | 1,250 | 1,750 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Sell | S | 2.85 | 87,500 | 249,463 | 318,198 | 405.7 K to 318.2 K (-21.57 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 22,067 | 63,994 | 405,698 | 427.8 K to 405.7 K (-5.16 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.60 | 40,000 | 64,000 | 427,765 | 387.8 K to 427.8 K (+10.32 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 9,865 | 28,609 | 387,765 | 397.6 K to 387.8 K (-2.48 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.10 | 26,009 | 28,610 | 397,630 | 371.6 K to 397.6 K (+7.00 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 31,955 | 92,670 | 371,621 | 403.6 K to 371.6 K (-7.92 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.53 | 174,849 | 92,670 | 403,576 | 228.7 K to 403.6 K (+76.44 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 30,956 | 89,772 | 228,727 | 259.7 K to 228.7 K (-11.92 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.85 | 105,616 | 89,774 | 259,683 | 154.1 K to 259.7 K (+68.55 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 35,202 | 102,086 | 154,067 | 189.3 K to 154.1 K (-18.60 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.65 | 61,870 | 102,086 | 189,269 | 127.4 K to 189.3 K (+48.56 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 5,345 | 15,501 | 127,399 | 132.7 K to 127.4 K (-4.03 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.55 | 10,000 | 15,500 | 132,744 | 122.7 K to 132.7 K (+8.15 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 10,621 | 30,801 | 122,744 | 133.4 K to 122.7 K (-7.96 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.54 | 20,000 | 30,800 | 133,365 | 113.4 K to 133.4 K (+17.64 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 9,655 | 28,000 | 113,365 | 123 K to 113.4 K (-7.85 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.40 | 20,000 | 28,000 | 123,020 | 103 K to 123 K (+19.41 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 603 | 1,749 | 103,020 | 103.6 K to 103 K (-0.58 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.40 | 1,250 | 1,750 | 103,623 | 102.4 K to 103.6 K (+1.22 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.70 | 1,250 | 875 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.90 | 2,000 | 1,800 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.95 | 500 | 475 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.01 | 2,000 | 2,020 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.32 | 500 | 660 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.40 | 2,000 | 2,800 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.10 | 2,000 | 2,200 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.06 | 16,500 | 17,490 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.13 | 500 | 565 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.30 | 5,750 | 7,475 | 0 | |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 302 | 876 | 102,373 | 102.7 K to 102.4 K (-0.29 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.70 | 1,250 | 875 | 102,675 | 101.4 K to 102.7 K (+1.23 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 621 | 1,801 | 101,425 | 102 K to 101.4 K (-0.61 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.90 | 2,000 | 1,800 | 102,046 | 100 K to 102 K (+2.00 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 164 | 476 | 100,046 | 100.2 K to 100 K (-0.16 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.95 | 500 | 475 | 100,210 | 99.7 K to 100.2 K (+0.50 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 697 | 2,021 | 99,710 | 100.4 K to 99.7 K (-0.69 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.01 | 2,000 | 2,020 | 100,407 | 98.4 K to 100.4 K (+2.03 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 228 | 661 | 98,407 | 98.6 K to 98.4 K (-0.23 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.32 | 500 | 660 | 98,635 | 98.1 K to 98.6 K (+0.51 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 966 | 2,801 | 98,135 | 99.1 K to 98.1 K (-0.97 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.40 | 2,000 | 2,800 | 99,101 | 97.1 K to 99.1 K (+2.06 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 759 | 2,201 | 97,101 | 97.9 K to 97.1 K (-0.78 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.10 | 2,000 | 2,200 | 97,860 | 95.9 K to 97.9 K (+2.09 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 6,031 | 17,490 | 95,860 | 101.9 K to 95.9 K (-5.92 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.06 | 16,500 | 17,490 | 101,891 | 85.4 K to 101.9 K (+19.32 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 195 | 566 | 85,391 | 85.6 K to 85.4 K (-0.23 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.13 | 500 | 565 | 85,586 | 85.1 K to 85.6 K (+0.59 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 2,578 | 7,476 | 85,086 | 87.7 K to 85.1 K (-2.94 %) |
May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.30 | 5,750 | 7,475 | 87,664 | 81.9 K to 87.7 K (+7.02 %) |
May 21 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 0.00 | 30,914 | 0 | 81,914 | 51 K to 81.9 K (+60.62 %) |
Page: 1